Advanced Enzyme Technologies Ltd

advancedenzymes.com BSE: 540025 NSE : ADVENZYMES
About [ edit ]

Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.#

Key Points [ edit ]
Website BSE NSE
  • Market Cap ₹ 5,288 Cr.
  • Current Price ₹ 473
  • High / Low ₹ 487 / 149
  • Stock P/E 36.3
  • Book Value ₹ 80.2
  • Dividend Yield 0.13 %
  • ROCE 23.1 %
  • ROE 17.0 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Promoter holding has decreased over last 3 years: -15.93%

Peer comparison

Sector: Chemicals Industry: Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
109 104 103 102 110 110 111 112 110 110 120 138
60 56 61 60 61 57 64 59 62 59 62 71
Operating Profit 48 48 42 42 50 53 47 53 49 52 59 66
OPM % 45% 46% 41% 41% 45% 48% 42% 47% 44% 47% 49% 48%
Other Income 1 0 2 0 3 1 2 1 2 5 1 1
Interest 4 1 2 -0 1 1 1 1 1 0 0 0
Depreciation 5 5 5 5 5 6 6 6 7 7 7 6
Profit before tax 40 42 37 37 46 47 42 47 43 50 52 61
Tax % 29% 26% 29% 31% 28% 28% 23% 26% 24% 30% 26% 27%
Net Profit 27 30 25 24 32 33 31 34 31 34 37 43
EPS in Rs 2.44 2.66 2.21 2.19 2.88 2.99 2.77 3.01 2.81 3.07 3.33 3.86
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
116 171 219 239 222 293 329 391 420 444 479
93 109 130 189 131 155 177 226 236 241 254
Operating Profit 23 62 90 50 91 138 152 165 184 203 225
OPM % 20% 36% 41% 21% 41% 47% 46% 42% 44% 46% 47%
Other Income 4 3 4 1 1 -3 3 1 5 6 9
Interest 3 12 10 13 9 8 4 9 5 4 2
Depreciation 5 6 8 10 9 9 13 18 21 26 27
Profit before tax 19 48 76 28 74 118 137 139 162 179 206
Tax % 10% 29% 34% 23% 31% 35% 32% 33% 28% 26%
Net Profit 17 33 49 20 50 76 92 90 111 129 146
EPS in Rs 1.62 3.22 4.52 1.85 4.60 6.97 8.20 8.07 9.95 11.58 13.07
Dividend Payout % 6% 1% 7% 6% 4% 3% 5% 6% 6% 5%
Compounded Sales Growth
10 Years:%
5 Years:15%
3 Years:11%
TTM:8%
Compounded Profit Growth
10 Years:%
5 Years:21%
3 Years:12%
TTM:12%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:28%
1 Year:196%
Return on Equity
10 Years:%
5 Years:20%
3 Years:17%
Last Year:17%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions
Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Sep 2020
21 21 22 22 22 22 22 22 22 22 22
Reserves 42 75 140 145 188 256 442 537 657 817 874
Borrowings 64 207 186 167 115 101 54 67 35 33 16
25 46 48 73 92 71 65 102 91 98 118
Total Liabilities 153 349 396 406 417 450 583 727 805 971 1,030
51 204 287 287 287 285 421 491 495 563 555
CWIP 19 60 2 2 5 7 8 11 10 10 8
Investments 0 0 0 0 0 0 0 0 111 124 103
82 84 107 117 125 158 153 226 188 275 364
Total Assets 153 349 396 406 417 450 583 727 805 971 1,030

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
16 49 41 43 54 93 107 116 129 141
-30 -187 -40 -25 -15 -10 -60 -60 -124 -43
27 128 -3 -20 -36 -63 -65 -2 -43 -39
Net Cash Flow 13 -10 -2 -1 2 21 -18 54 -38 60

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 28% 26% 12% 25% 37% 32% 26% 25% 23%
Debtor Days 70 70 65 49 61 52 55 55 51 61
Inventory Turnover 2.58 1.81 1.31 1.13 1.27 1.30 1.38 1.27 1.27

Shareholding Pattern

Numbers in percentages

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
67.34 67.34 67.27 57.31 57.30 57.86 57.86 57.88 58.13 55.45 55.39 55.38
3.48 3.33 4.02 11.08 11.17 11.19 10.96 11.12 11.02 16.01 17.11 16.79
7.26 7.63 7.70 8.26 8.11 8.36 8.68 8.89 8.69 6.32 6.28 7.32
21.92 21.70 21.00 23.35 23.42 22.59 22.50 22.11 22.16 22.23 21.22 20.51

Documents

Recent announcements


View all

Annual reports

Credit ratings

Concalls